Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Molecular analysis of a CD19-negative diffuse large B-cell lymphoma.

Delage L, Manzoni D, Quinquenet C, Fontaine J, Maarek A, Chabane K, Mosnier I, Hayette S, Callet-Bauchu E, Grange B, Plesa A, Sujobert P.

Haematologica. 2019 Mar;104(3):e114-e116. doi: 10.3324/haematol.2018.203521. Epub 2018 Dec 13. No abstract available.

2.

Holistic approach in patients with presumed Lyme borreliosis leads to less than 10% of confirmation and more than 80% of antibiotics failure.

Haddad E, Chabane K, Jaureguiberry S, Monsel G, Pourcher V, Caumes E.

Clin Infect Dis. 2018 Sep 18. doi: 10.1093/cid/ciy799. [Epub ahead of print]

PMID:
30239603
3.

Validation of the prognostic value of the knowledge bank approach to determine AML prognosis in real life.

Huet S, Paubelle E, Lours C, Grange B, Courtois L, Chabane K, Charlot C, Mosnier I, Simonet T, Hayette S, Tigaud I, Thomas X, Salles G, Subtil F, Sujobert P.

Blood. 2018 Aug 23;132(8):865-867. doi: 10.1182/blood-2018-03-840348. Epub 2018 Jun 4. No abstract available.

PMID:
29866812
4.

What Does This Mutation Mean? The Tools and Pitfalls of Variant Interpretation in Lymphoid Malignancies.

Guillermin Y, Lopez J, Chabane K, Hayette S, Bardel C, Salles G, Sujobert P, Huet S.

Int J Mol Sci. 2018 Apr 20;19(4). pii: E1251. doi: 10.3390/ijms19041251. Review.

5.

Single, short in-del, and copy number variations detection in monogenic dyslipidemia using a next-generation sequencing strategy.

Marmontel O, Charrière S, Simonet T, Bonnet V, Dumont S, Mahl M, Jacobs C, Nony S, Chabane K, Bozon D, Janin A, Peretti N, Lachaux A, Bardel C, Millat G, Moulin P, Marçais C, Di Filippo M.

Clin Genet. 2018 Jul;94(1):132-140. doi: 10.1111/cge.13250. Epub 2018 Apr 25.

PMID:
29572815
6.

Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma.

Jallades L, Baseggio L, Sujobert P, Huet S, Chabane K, Callet-Bauchu E, Verney A, Hayette S, Desvignes JP, Salgado D, Levy N, Béroud C, Felman P, Berger F, Magaud JP, Genestier L, Salles G, Traverse-Glehen A.

Haematologica. 2017 Oct;102(10):1758-1766. doi: 10.3324/haematol.2016.160192. Epub 2017 Jul 27.

7.

Erratum to: BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib.

Heiblig M, Bidet A, Callet-Bauchu E, Dumas PY, Chabane K, Salles G, Pigneux A.

Ann Hematol. 2017 Feb;96(2):337. doi: 10.1007/s00277-016-2879-4. No abstract available.

PMID:
27864605
8.

Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies.

Traverse-Glehen A, Verney A, Gazzo S, Jallades L, Chabane K, Hayette S, Coiffier B, Callet-Bauchu E, Ffrench M, Felman P, Berger F, Baseggio L, Salles G.

Leuk Lymphoma. 2017 Mar;58(3):666-675. doi: 10.1080/10428194.2016.1196813. Epub 2016 Jun 27.

PMID:
27347751
9.

Increased monocyte/neutrophil and pro-coagulant microparticle levels and overexpression of aortic endothelial caveolin-1β in dyslipidemic sand rat, Psammomys obesus.

Ousmaal Mel F, Martínez MC, Andriantsitohaina R, Chabane K, Gaceb A, Mameri S, Giaimis J, Baz A.

J Diabetes Complications. 2016 Jan-Feb;30(1):21-9. doi: 10.1016/j.jdiacomp.2015.09.017. Epub 2015 Oct 3.

PMID:
26597597
10.

Molecular characterization and follow-up of five CML patients with new BCR-ABL1 fusion transcripts.

Huet S, Dulucq S, Chauveau A, Ménard A, Chomel JC, Maisonneuve H, Legros L, Perrin MC, Ferrant E, Moreilhon C, Couturier MA, Sujobert P, Magaud JP, Ugo V, Chabane K, Raynaud S, Hayette S; GBMHM (Groupe des Biologistes Moléculaires des Hémopathies Malignes, French Molecular Biology Group in Hematology).

Genes Chromosomes Cancer. 2015 Oct;54(10):595-605. doi: 10.1002/gcc.22263. Epub 2015 Aug 7.

PMID:
26252834
11.

New Quantitative Method to Identify NPM1 Mutations in Acute Myeloid Leukaemia.

Huet S, Jallades L, Charlot C, Chabane K, Nicolini FE, Michallet M, Magaud JP, Hayette S.

Leuk Res Treatment. 2013;2013:756703. doi: 10.1155/2013/756703. Epub 2013 Apr 9.

12.

High DNA methyltransferase DNMT3B levels: a poor prognostic marker in acute myeloid leukemia.

Hayette S, Thomas X, Jallades L, Chabane K, Charlot C, Tigaud I, Gazzo S, Morisset S, Cornillet-Lefebvre P, Plesa A, Huet S, Renneville A, Salles G, Nicolini FE, Magaud JP, Michallet M.

PLoS One. 2012;7(12):e51527. doi: 10.1371/journal.pone.0051527. Epub 2012 Dec 10.

13.

The durable clearance of the T315I BCR-ABL mutated clone in chronic phase chronic myelogenous leukemia patients on omacetaxine allows tyrosine kinase inhibitor rechallenge.

Nicolini FE, Chomel JC, Roy L, Legros L, Chabane K, Ducastelle S, Nicolas-Virelizier E, Michallet M, Tigaud I, Magaud JP, Turhan A, Guilhot F, Hayette S.

Clin Lymphoma Myeloma Leuk. 2010 Oct;10(5):394-9. doi: 10.3816/CLML.2010.n.073.

PMID:
21030353
14.

Longitudinal studies of SRC family kinases in imatinib- and dasatinib-resistant chronic myelogenous leukemia patients.

Hayette S, Chabane K, Michallet M, Michallat E, Cony-Makhoul P, Salesse S, Maguer-Satta V, Magaud JP, Nicolini FE.

Leuk Res. 2011 Jan;35(1):38-43. doi: 10.1016/j.leukres.2010.06.030. Epub 2010 Jul 29.

PMID:
20673586
15.

Pegylated IFN-α2a combined to imatinib mesylate 600mg daily can induce complete cytogenetic and molecular responses in a subset of chronic phase CML patients refractory to IFN alone or to imatinib 600mg daily alone.

Nicolini FE, Hayette S, Legros L, Rousselot P, Maloisel F, Tulliez M, Guerci A, Charbonnier A, Prébet T, Rigal-Huguet F, Chabane K, Magaud JP, Paillet C, Pivot C, Michallet M.

Leuk Res. 2011 Jan;35(1):80-6. doi: 10.1016/j.leukres.2010.04.010. Epub 2010 Jun 3.

PMID:
20605207
16.

Detection of twelve nucleotides insertion in the BCR-ABL kinase domain in an imatinib-resistant but dasatinib-sensitive patient with bi-phenotypic acute leukemia.

Hayette S, Chabane K, Tchirkov A, Berger MG, Nicolini FE, Tournilhac O.

Haematologica. 2009 Sep;94(9):1324-6. doi: 10.3324/haematol.2009.007864. No abstract available.

17.

BCR-ABL(T315I) transcript disappearance in an imatinib-resistant CML patient treated with homoharringtonine: a new therapeutic challenge?

Legros L, Hayette S, Nicolini FE, Raynaud S, Chabane K, Magaud JP, Cassuto JP, Michallet M.

Leukemia. 2007 Oct;21(10):2204-6. Epub 2007 May 31. No abstract available.

PMID:
17541396
18.

BCR-ABL mutant kinetics in CML patients treated with dasatinib.

Nicolini FE, Chabane K, Tigaud I, Michallet M, Magaud JP, Hayette S.

Leuk Res. 2007 Jun;31(6):865-8. Epub 2007 Jan 8.

PMID:
17208297
19.

The role of the K247R substitution in the ABL tyrosine kinase domain in sensitivity to imatinib.

Nicolini FE, Chabane K, Cayuela JM, Rousselot P, Thomas X, Hayette S.

Haematologica. 2006 Jan;91(1):137-8.

20.

Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib.

Cayuela JM, Rousselot P, Nicolini F, Espinouse D, Ollagnier C, Bui-Thi MH, Chabane K, Raffoux E, Callet-Bauchu E, Tigaud I, Magaud JP, Hayette S.

Leukemia. 2005 Dec;19(12):2334-6. No abstract available.

PMID:
16224485
21.

Characterization of genetic variation in and phylogenetic relationships among diploid Aegilops species by AFLP: incongruity of chloroplast and nuclear data.

Sasanuma T, Chabane K, Endo TR, Valkoun J.

Theor Appl Genet. 2004 Feb;108(4):612-8. Epub 2003 Oct 29.

PMID:
14586506

Supplemental Content

Loading ...
Support Center